Tanım

Materials used in orthopaedic implants are generally used for fracture fixation enhancement, joint replacement or dynamic stabilization. These include reconstructive implants, fracture management products, spinal products, rehabilitation products, arthroscopy products, electrical stimulation products, casting products etc. StratejiHelix'e göre, the global orthopedic biomaterial market is expected to increase by US$ 11.5 sırasında milyar 2022-2028, expanding at a CAGR of 7.1% tahmin dönemi boyunca.

Rapor, döneme ilişkin güncel pazar büyüklüğü verilerini sağlar 2018-2021 ve tahmin 2028 covering key market aspects like sales value for orthopedic biomaterial. The global orthopedic biomaterial market is segmented on the basis of product, malzeme, end user, ve bölge. Ürün bazında, the global orthopedic biomaterial market is categorized into dental implants, joint replacement/reconstruction, orthobiologics, spinal implants, trauma, diğerleri. The joint replacement/reconstruction segment held the largest share of the global orthopedic biomaterial market in 2021 ve tahmin dönemi boyunca payını koruması bekleniyor. On the basis of material, the global orthopedic biomaterial market has been segmented into metals and alloys, polymers, ceramics. Globally, the metals and alloys segment made up the largest share of the orthopedic biomaterial market. By end user, the global orthopedic biomaterial market has been segmented into hospitals & clinics, ambulatory surgical centers (ASC'ler), diğerleri. coğrafi olarak, the global orthopedic biomaterial market is segmented into North America, Asya Pasifik, Avrupa, Dünyanın Geri Kalanı (ROW).

The global orthopedic biomaterial market is highly competitive. The leading players in the orthopedic biomaterial market include CAM Bioceramics B.V., Collagen Matrix Inc., CoorsTek Inc., DePuy Synthes Inc., Evonik Industries AG, Exactech Inc., Globus Medical Inc., Heraeus Holding GmbH, Institut Straumann AG (İsviçre), Koninklijke DSM N.V. (DSM Biomedical B.V.), Kyocera Şirketi, Smith & Nephew Plc., Stryker Corporation, Victrex PLC (Invibio Ltd.), Zimmer Biomet Holdings Inc.

Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the orthopedic biomaterial market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.

Rapor Kapsamı

Ürün: dental implants, joint replacement/reconstruction, orthobiologics, spinal implants, trauma, diğerleri
Malzeme: metals and alloys, polymers, ceramics
End user: hospitals & clinics, ambulatory surgical centers (ASC'ler), diğerleri
Bölge: Kuzey Amerika, Asya Pasifik, Avrupa, Dünyanın Geri Kalanı (ROW)
Dikkate alınan yıllar: bu rapor dönemi kapsamaktadır 2018 ile 2028

Paydaşlar için Temel Faydalar

– Get a comprehensive picture of the global orthopedic biomaterial market
– Büyüme sektörlerini ve yatırım eğilimlerini belirleyin

İçindekiler

Parça 1. giriiş
– Çalışmanın kapsamı
– Çalışma periyodu
– Coğrafik kapsam
– Araştırma metodolojisi
Parça 2. Orthopedic biomaterial market overview
Parça 3. Market breakdown by product
– Dental implants
– Joint replacement/reconstruction
– Orthobiologics
– Spinal implants
– Trauma
– Diğerleri
Parça 4. Market breakdown by material
– Metals and alloys
– Polymers
– Ceramics
Parça 5. Market breakdown by end user
– Hastaneler & clinics
– Ambulatory surgical centers (ASC'ler)
– Diğerleri
Parça 6. Market breakdown by region
– Kuzey Amerika
– Asya Pasifik
– Avrupa
– Dünyanın Geri Kalanı (ROW)
Parça 7. Anahtar şirketler
– CAM Bioceramics B.V.
– Collagen Matrix Inc.
– CoorsTek Inc.
– DePuy Synthes Inc.
– Evonik Industries AG
– Exactech Inc.
– Globus Medical Inc.
– Heraeus Holding GmbH
– Institut Straumann AG (İsviçre)
– Koninklijke DSM N.V. (DSM Biomedical B.V.),
– Kyocera Şirketi
– Smith & Nephew Plc.
– Stryker Corporation
– Victrex PLC (Invibio Ltd.)
– Zimmer Biomet Holdings Inc.
StratejiHelix Hakkında
Sorumluluk reddi beyanı